Publication: Type 3 neovascularisation (retinal angiomatous proliferation) treated with antivascular endothelial growth factor: real-world outcomes at 24 months
Type 3 neovascularisation (retinal angiomatous proliferation) treated with antivascular endothelial growth factor: real-world outcomes at 24 months
Date
Date
Date
Citations
Invernizzi, A., Teo, K., Nguyen, V., Daniell, M., Squirrell, D., Barthelmes, D., & Gillies, M. C. (2019). Type 3 neovascularisation (retinal angiomatous proliferation) treated with antivascular endothelial growth factor: real-world outcomes at 24 months. The British Journal of Ophthalmology, 103, 1337–1341. https://doi.org/10.1136/bjophthalmol-2018-312944
Abstract
Abstract
Abstract
AIMS To compare 24 months outcomes of eyes with retinal angiomatous proliferations (RAPs) treated with antivascular endothelial growth factor (anti-VEGF) with a group of controls diagnosed with other neovascular age-related macular degeneration (nAMD) subtypes in a real-world setting. METHODS Treatment-naïve nAMD eyes that commenced anti-VEGF between January 2006 and November 2015 were identified from a registry of nAMD treatment outcomes. Cases were defined as eyes diagnosed with RAP. Three controls per case were selected among nAMD
Additional indexing
Creators (Authors)
- Invernizzi, Alessandro
- Teo, Kelvin
- Nguyen, Vuong
- Daniell, Mark
- Squirrell, David
- Barthelmes, Daniel
- Gillies, Mark C
Volume
Volume
Volume
Number
Number
Number
Page range/Item number
Page range/Item number
Page range/Item number
Page end
Page end
Page end
Item Type
Item Type
Item Type
In collections
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Language
Language
Language
Publication date
Publication date
Publication date
Date available
Date available
Date available
ISSN or e-ISSN
ISSN or e-ISSN
ISSN or e-ISSN
OA Status
OA Status
OA Status
Free Access at
Free Access at
Free Access at
Publisher DOI
Citations
Invernizzi, A., Teo, K., Nguyen, V., Daniell, M., Squirrell, D., Barthelmes, D., & Gillies, M. C. (2019). Type 3 neovascularisation (retinal angiomatous proliferation) treated with antivascular endothelial growth factor: real-world outcomes at 24 months. The British Journal of Ophthalmology, 103, 1337–1341. https://doi.org/10.1136/bjophthalmol-2018-312944
